Drawing for PHOTODOX

USPTO serial 98621217

PHOTODOX

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CHUNG, DIANA ALANA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with PHOTODOX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ryan S. Hilbert

Ryan S. Hilbert Holley & Menker PAPO Box 331937Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical products for the treatment of viral and infectious diseases for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseasesACTIVE—
042Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 29, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 28, 2026EX2GSOU EXTENSION 2 GRANTED—
Apr 28, 2026EXT2SOU EXTENSION 2 FILED—
Apr 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 6, 2025EX1GSOU EXTENSION 1 GRANTED—
Nov 5, 2025EXT1SOU EXTENSION 1 FILED—
Nov 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2025DOCKASSIGNED TO EXAMINER—
Jan 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 27, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance